Skip to main content
NCBI home page
Canadian Journal of Public Health = Revue Canadienne de Santé Publique logoLink to Canadian Journal of Public Health = Revue Canadienne de Santé Publique
. 2001 Jan 1;92(1):9–10. doi: 10.1007/BF03404835

Controlling the Ischemic Heart Disease Epidemic: Strategies for the 21st Century

Sumit R Majumdar 13,33, Ross T Tsuyuki 23,33, Finlay A McAlister 13,33,✉
PMCID: PMC6979781  PMID: 11257999

The content is available as a PDF (73.3 KB).

Footnotes

Supported, in part, by the Alberta Heritage Foundation for Medical Research (F.M.) and the University of Alberta Hospital Foundation (R.T.).

References

  • 1.McKeown T. The Role of Medicine: Dream, Mirage, or Nemesis? 2nd edition. Princeton, NJ: Princeton University Press; 1979. [Google Scholar]
  • 2.Chan B, Coyte P, Heick C. Economic impact of cardiovascular disease in Canada. Can J Cardiol. 1996;12:1000–06. [PubMed] [Google Scholar]
  • 3.Doll R. The Value of Preventive Medicine, Proceedings from the CIBA Foundation Symposium. London: Pitman; 1985. Preventive medicine: The objectives; pp. 3–21. [DOI] [PubMed] [Google Scholar]
  • 4.Woolf SH. The need for perspective in evidence-based medicine. JAMA. 1999;282:2358–65. doi: 10.1001/jama.282.24.2358. [DOI] [PubMed] [Google Scholar]
  • 5.Smith CA, Pratt M. Cardiovascular disease epidemiology. In: Brownson RC, Remington PL, Davis JR, editors. Chronic Disease Epidemiology and Control. Washington: American Public Health Association; 1993. pp. 83–109. [Google Scholar]
  • 6.Rose G. The Strategy of Preventive Medicine. New York: Oxford University Press; 1998. [Google Scholar]
  • 7.Kottke TE, Puska P, Salonen JT, et al. Projected effects of high-risk versus population-based prevention strategies in coronary heart disease. Am J Epidemiol. 1985;121:697–704. doi: 10.1093/aje/121.5.697. [DOI] [PubMed] [Google Scholar]
  • 8.Russell LB. Is Prevention Better than Cure? Washington: Brookings Institution; 1986. [Google Scholar]
  • 9.Nusselder WJ, van der Velden K, van Sonsbeek JLA, et al. The elimination of selected chronic diseases in a population: The compression and expansion of morbidity. Am J Public Health. 1996;86:187–94. doi: 10.2105/AJPH.86.2.187. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Sytkowski PA, Kannel WB, D’Agostino RB. Changes in risk factors and the decline in mortality from cardiovascular disease: The Framingham Heart Study. N Engl J Med. 1990;322:1635–41. doi: 10.1056/NEJM199006073222304. [DOI] [PubMed] [Google Scholar]
  • 11.Hunink MGM, Goldman L, Tosteson ANA, et al. The recent decline in mortality from coronary heart disease, 1980–1990. The effect of secular trends in risk factors and treatment. JAMA. 1997;277:535–42. doi: 10.1001/jama.1997.03540310033031. [DOI] [PubMed] [Google Scholar]
  • 12.Pincus T, Esther R, DeWalt DA, Callahan LF. Social conditions and self-management are more powerful determinants of health than access to care. Ann Intern Med. 1998;129:406–11. doi: 10.7326/0003-4819-129-5-199809010-00011. [DOI] [PubMed] [Google Scholar]
  • 13.Marmot MG, Kogevinas M, Elston MA. Socio-economic status and disease. Annu Rev Public Health. 1987;8:111–35. doi: 10.1146/annurev.pu.08.050187.000551. [DOI] [PubMed] [Google Scholar]
  • 14.Millar WJ, Wigle DT. Socioeconomic disparities in risk factors for cardiovascular disease. Can Med Assoc J. 1986;134:127–32. [PMC free article] [PubMed] [Google Scholar]
  • 15.Kaplan NM. Evidence in favor of moderate dietary sodium restriction. Am J Hypertension. 2000;13:8–13. doi: 10.1016/S0895-7061(99)00242-3. [DOI] [PubMed] [Google Scholar]
  • 16.Alderman MH, Cohen H, Madhaven S. Dietary sodium intake and mortality: NHANES 1. Lancet. 1998;351:781–85. doi: 10.1016/S0140-6736(97)09092-2. [DOI] [PubMed] [Google Scholar]
  • 17.Caro J, Klittich W, McGuire A, et al. West of Scotland coronary prevention study: Economic benefit analysis of primary prevention with pravastatin. BMJ. 1997;315:1577–82. doi: 10.1136/bmj.315.7122.1577. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Tosteson ANA, Weinstein MC, Hunink MGM, et al. Cost-effectiveness of populationwide educational approaches to reduce serum cholesterol levels. Circulation. 1997;95:24–30. doi: 10.1161/01.CIR.95.1.24. [DOI] [PubMed] [Google Scholar]
  • 19.Manson JE, Tosteson H, Ridkeer PM, et al. The primary prevention of myocardial infarction. N Engl J Med. 1992;326:1406–16. doi: 10.1056/NEJM199205213262107. [DOI] [PubMed] [Google Scholar]
  • 20.Wilkinson R. Unhealthy Societies: The Afflictions of Inequality. London: Routledge Press; 1997. [Google Scholar]
  • 21.Multiple Risk Factor Intervention Trial Research Group. Relationship between baseline risk factors and coronary heart disease and total mortality in the Multiple Risk Factor Intervention Trial. Prev Med. 1986;15:254–73. doi: 10.1016/0091-7435(86)90045-9. [DOI] [PubMed] [Google Scholar]
  • 22.Johannesson M, Jonsson B, Kjekshus J, et al. Cost effectiveness of simvastatin treatment to lower cholesterol levels in patients with coronary heart disease. New Engl J Med. 1997;336:332–36. doi: 10.1056/NEJM199701303360503. [DOI] [PubMed] [Google Scholar]
  • 23.McAlister FA, Taylor L, Teo KK, et al. The treatment and prevention of coronary heart disease in Canada: Do older patients receive efficacious therapies? J Am Geriatr Soc. 1999;47:811–18. doi: 10.1111/j.1532-5415.1999.tb03837.x. [DOI] [PubMed] [Google Scholar]
  • 24.Cox JL. Optimizing disease management at a health care system level: The rationale and methods of the Improving Cardiovascular Outcomes in Nova Scotia (ICONS) study. Can J Cardiol. 1999;15:787–96. [PubMed] [Google Scholar]

Articles from Canadian Journal of Public Health = Revue Canadienne de Santé Publique are provided here courtesy of Springer

RESOURCES